Your account is not claimed yet. You can sign up with ORCID to claim your account.

Michael J Haller (Laura Jacobsen, Laura M Jacobsen)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 20

Top Venues

Diabetes care

Pediatric diabetes

Diabetes

Diabetes technology & therapeutics

University of Florida

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Florida Jul 1o 2018

United States

Pediatric Endocrinologist :: Pediatrics

Publications

Jay M Sosenko, David Cuthbertson, Emily K Sims, Heba M Ismail, Brandon M Nathan, Michael J Haller, Mark A Atkinson, Carmella Evans-Molina, Kevan C Herold, Jay S Skyler, Maria Jose Redondo, null null
Phenotypes Associated With Zones Defined by Area Under the Curve Glucose and C-peptide in a Population With Islet Autoantibodies. Diabetes care (2023)
Rachel K Baker, Stephanie L Filipp, Michael J Haller
Type 1 Diabetes Continuous Glucose Monitoring Use in the Pediatric Emergency Department Affects Laboratory Test Frequency but Not Treatment Timing. Diabetes spectrum : a publication of the American Diabetes Association 36 (3) (2023)
Michael J Haller, Laura E Bocchino, John W Lum, Craig Kollman, Victoria Barnes-Lomen, Mark Sulik, Michael J Haller, Bruce Bode, Joseph T Cernich, Anthony A Killeen, Uttam Garg, David Liljenquist, Janey G Adams, Margaret Clements, Deanna Gabrielson, Terri Johnson, Mark A Clements, Roy W Beck
Accuracy of Three Commercial Home-Use Hemoglobin A1c Tests. Diabetes technology & therapeutics 24 (11) (2022)
Carla Demeterco-Berggren, Osagie A Ebekozien, Nudrat Noor, Saketh Rompicherla, Shideh Majidi, Nana-Hawa Yayah Jones, Ryan McDonough, Ori Odugbesan, Ahlee Kim, Roberto Izquierdo, Manmohan K Kamboj, Michael J Haller
Factors Associated With Achieving Target A1C in Children and Adolescents With Type 1 Diabetes: Findings From the T1D Exchange Quality Improvement Collaborative. Clinical diabetes : a publication of the American Diabetes Association 41 (1) (2022)
Rachel E J Besser, Kirstine J Bell, Jennifer J Couper, Anette-G Ziegler, Diane K Wherrett, Olli H Laitinen, Cate Speake, Kristina Casteels, Kimberly A Driscoll, Michael J Haller, Maria E Craig, Michael J Haller
ISPAD clinical practice consensus guidelines 2022: Stages of type 1 diabetes in children and adolescents. Pediatric diabetes (2022)
Michael J Haller, Brian N Bundy, Heba M Ismail, Mark Clements, Megan Warnock, Susan Geyer, Desmond A Schatz, Jay M Sosenko
Index60 Is Superior to HbA1c for Identifying Individuals at High Risk for Type 1 Diabetes. The Journal of clinical endocrinology and metabolism 107 (10) (2022)
Michael J Haller, Kendra Vehik, Riitta Veijola, Katharina Warncke, Jorma Toppari, Andrea K Steck, Patricia Gesualdo, Beena Akolkar, Markus Lundgren, William A Hagopian, Jin-Xiong She, Marian Rewers, Anette-G Ziegler, Jeffrey P Krischer, Helena Elding Larsson, Michael J Haller, null null
Heterogeneity of DKA Incidence and Age-Specific Clinical Characteristics in Children Diagnosed With Type 1 Diabetes in the TEDDY Study. Diabetes care 45 (3) (2022)
Carla Demeterco-Berggren, Osagie A Ebekozien, Nudrat Noor, Saketh Rompicherla, Shideh Majidi, Nana-Hawa Yayah Jones, Ryan McDonough, Ori Odugbesan, Ahlee Kim, Roberto Izquierdo, Manmohan K Kamboj, Michael J Haller
Factors Associated With Achieving Target A1C in Children and Adolescents With Type 1 Diabetes: Findings From the T1D Exchange Quality Improvement Collaborative. Clinical diabetes : a publication of the American Diabetes Association 41 (1) (2022)
Helmut Hiller, Dawn E Beachy, Joseph J Lebowitz, Stefanie Engler, Justin R Mason, Douglas R Miller, Irina Kusmarteva, Michael J Haller, Amanda L Posgai, Habibeh Khoshbouei, Richard D Oram, Desmond A Schatz, Andrew T Hattersley, Bernd Bodenmiller, Mark A Atkinson, Harry S Nick, Clive H Wasserfall
Monogenic Diabetes and Integrated Stress Response Genes Display Altered Gene Expression in Type 1 Diabetes. Diabetes 70 (8) (2021)
Kimberly A Driscoll, Roy Tamura, Suzanne Bennett Johnson, Patricia Gesualdo, Joanna Clasen, Laura B Smith, Michael J Haller, Helena Elding Larsson, Michael J Haller, null null
Adherence to oral glucose tolerance testing in children in stage 1 of type 1 diabetes: The TEDDY study. Pediatric diabetes 22 (2) (2021)
Hai V Nguyen, Desmond A Schatz, Shweta Mital, Michael J Haller, Michael J Haller
Cost-Effectiveness of Low-Dose Antithymocyte Globulin Versus Other Immunotherapies for Treatment of New-Onset Type 1 Diabetes. Diabetes technology & therapeutics (2021)
Michael J Haller, Michael J Haller, Amanda L Posgai, Desmond A Schatz
How Do We Move Type 1 Diabetes Immunotherapies Forward During the Current COVID-19 Pandemic? Diabetes 70 (5) (2021)
Andrea Lin, Jasmine A Mack, Brittany S Bruggeman, Michael J Haller, Amanda L Posgai, Clive H Wasserfall, Todd M Brusko, Mark A Atkinson, Stephen E Gitelman, Peter A Gottlieb, Matthew J Gurka, Clayton E Mathews, Desmond A Schatz, Michael J Haller
Low-Dose ATG/GCSF in Established Type 1 Diabetes: A Five-Year Follow-up Report. Diabetes 70 (5) (2021)
Brittany S Bruggeman, Chelsea Zimmerman, Amanda LaPorte, Michael Stalvey, Stephanie L Filipp, Matthew J Gurka, Janet H Silverstein, Michael J Haller
Barriers to retinopathy screening in youth and young adults with type 1 diabetes. Pediatric diabetes 22 (3) (2020)
Michael J Haller, Laura Bocchino, Carmella Evans-Molina, Linda DiMeglio, Robin Goland, Darrell M Wilson, Mark A Atkinson, Tandy Aye, William E Russell, John M Wentworth, David Boulware, Susan Geyer, Jay M Sosenko
The risk of progression to type 1 diabetes is highly variable in individuals with multiple autoantibodies following screening. Diabetologia 63 (3) (2019)
Manuela Battaglia, Simi Ahmed, Mark S Anderson, Mark A Atkinson, Dorothy Becker, Polly J Bingley, Emanuele Bosi, Todd M Brusko, Linda A DiMeglio, Carmella Evans-Molina, Stephen E Gitelman, Carla J Greenbaum, Peter A Gottlieb, Kevan C Herold, Martin J Hessner, Olli H Laitinen, Michael J Haller, Jeffrey P Krischer, Sarah Alice Long, Markus Lundgren, Eoin F McKinney, Noel G Morgan, Richard D Oram, Tomi Pastinen, Michael C Peters, Alessandra Petrelli, Xiaoning Qian, Maria Jose Redondo, Bart O Roep, Desmond Schatz, David Skibinski, Mark Peakman
Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes. Diabetes care 43 (1) (2019)
Emily K Sims, Susan Geyer, Suzanne Bennett Johnson, Ingrid Libman, Michael J Haller, David Boulware, Lisa E Rafkin, Della Matheson, Mark A Atkinson, Henry Rodriguez, Maria Spall, Helena Elding Larsson, Diane K Wherrett, Carla J Greenbaum, Jeffrey Krischer, Linda A DiMeglio, null null
Who Is Enrolling? The Path to Monitoring in Type 1 Diabetes TrialNet's Pathway to Prevention. Diabetes care 42 (12) (2019)
Michael J Haller, Helena Elding Larsson, Roy N Tamura, Kendra Vehik, Joanna Clasen, Jay Sosenko, William A Hagopian, Jin-Xiong She, Andrea K Steck, Marian Rewers, Olli Simell, Jorma Toppari, Riitta Veijola, Anette G Ziegler, Jeffrey P Krischer, Beena Akolkar, Michael J Haller, null null
Predicting progression to type 1 diabetes from ages 3 to 6 in islet autoantibody positive TEDDY children. Pediatric diabetes 20 (3) (2019)
Maria L Beery, Michael J Haller, Mark A Atkinson, Alexandra E Butler, Martha L Campbell-Thompson
Islet amyloidosis in a child with type 1 diabetes. Islets 11 (2) (2019)
Laura M Jacobsen, Michael J Haller, Alice Parish, Matthew J Gurka, S Robert Levine, Clive Wasserfall, Martha Campbell-Thompson, John Kaddis, Alberto Pugliese, Mark A Atkinson, Desmond A Schatz
High Illicit Drug Abuse and Suicide in Organ Donors With Type 1 Diabetes. Diabetes care 40 (9) (2017)

Michael J Haller.css-eqlu8i{font-size:small;padding-left:4px;} (Laura Jacobsen, Laura M Jacobsen)

Publication Activity (10 Years)

Top Topics

Top Venues

Michael J Haller (Laura Jacobsen, Laura M Jacobsen)